Literature DB >> 9440618

Codon 201Arg/Gly polymorphism of DCC (deleted in colorectal carcinoma) gene in flat- and polypoid-type colorectal tumors.

R Minami1, N Aoyama, Y Honsako, M Kasuga, T Fujimori, S Maeda.   

Abstract

Recent studies have identified the distinct existence of flat-type colorectal tumors. The low incidence of ras gene mutations in these tumors suggests that their genetic pathways of tumor progression may be different from those of the polypoid type. To elucidate further genetic alterations in flat-type colorectal tumors, codon 201Arg/Gly polymorphism in the DCC (deleted in colorectal carcinoma) gene was analyzed in normal tissue (normal colonic mucosa or peripheral lymphocytes) and in tumor tissue from 191 patients with colorectal tumors (36 patients with flat-type colorectal tumors, 81 patients with polypoid-type colorectal tumors, and 74 patients with advanced carcinomas). For normal controls, 30 samples obtained from patients who had neither colorectal tumors (confirmed by total colonoscopy) nor a family history of colorectal carcinoma were analyzed. DCC gene codon 201Arg/Gly polymorphism was investigated by polymerase chain reaction-based restriction fragment length polymorphism analysis, fluorescence-based dideoxy sequencing, or both. For the flat type, the frequency of codon 201Gly of the DCC gene was 64% and 54% in the normal tissue of patients with adenoma with high-grade dysplasia and submucosal carcinoma, respectively. It was 49%, 52%, and 49% in the normal tissue of patients with polypoid-type adenoma with high-grade dysplasia, submucosal carcinoma, and advanced carcinoma, respectively. In the normal tissue, codon 201Gly of the DCC gene was more frequently observed in patients with flat-type adenoma with low-grade dysplasia (67%) than in those with polypoid-type adenoma with low-grade dysplasia (18%) or in normal controls (17%, P < 0.05, chi2 test). Codon 201Arg/Gly polymorphism in tumor tissues did not differ from that in the corresponding normal tissues, except for 10 cases of carcinoma with loss of heterozygosity (LOH). In carcinomas with LOH, preferential loss of the codon 201Arg allele was noted (9/10 cases). These results suggest that codon 201Gly of the DCC gene is not only associated with flat-type colorectal tumors, but that it may serve as a useful genetic marker for identifying groups at higher risk for colorectal cancer.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9440618     DOI: 10.1023/a:1018839907159

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  31 in total

1.  Polymerase chain reaction microanalysis of tumors from stained histological slides.

Authors:  L Whetsell; G Maw; N Nadon; D P Ringer; F V Schaefer
Journal:  Oncogene       Date:  1992-11       Impact factor: 9.867

2.  Deleted in Colorectal Cancer (DCC) encodes a netrin receptor.

Authors:  K Keino-Masu; M Masu; L Hinck; E D Leonardo; S S Chan; J G Culotti; M Tessier-Lavigne
Journal:  Cell       Date:  1996-10-18       Impact factor: 41.582

3.  The DCC gene: structural analysis and mutations in colorectal carcinomas.

Authors:  K R Cho; J D Oliner; J W Simons; L Hedrick; E R Fearon; A C Preisinger; P Hedge; G A Silverman; B Vogelstein
Journal:  Genomics       Date:  1994-02       Impact factor: 5.736

4.  p53 mutations in flat- and polypoid-type colorectal tumors detected by temperature-gradient gel electrophoresis.

Authors:  Y Yamamura-Idei; K Satonaka; T Fujimori; S Maeda; T Chiba
Journal:  Dig Dis Sci       Date:  1994-09       Impact factor: 3.199

5.  Identification of a chromosome 18q gene that is altered in colorectal cancers.

Authors:  E R Fearon; K R Cho; J M Nigro; S E Kern; J W Simons; J M Ruppert; S R Hamilton; A C Preisinger; G Thomas; K W Kinzler
Journal:  Science       Date:  1990-01-05       Impact factor: 47.728

6.  Flat adenomas of the colon.

Authors:  R A Wolber; D A Owen
Journal:  Hum Pathol       Date:  1991-01       Impact factor: 3.466

7.  Progression of colorectal cancer is associated with multiple tumor suppressor gene defects but inhibition of tumorigenicity is accomplished by correction of any single defect via chromosome transfer.

Authors:  M C Goyette; K Cho; C L Fasching; D B Levy; K W Kinzler; C Paraskeva; B Vogelstein; E J Stanbridge
Journal:  Mol Cell Biol       Date:  1992-03       Impact factor: 4.272

8.  Flat early cancers of the large intestine.

Authors:  S Kuramoto; T Oohara
Journal:  Cancer       Date:  1989-08-15       Impact factor: 6.860

9.  Genetic changes and histopathological types in colorectal tumors from patients with familial adenomatous polyposis.

Authors:  M Miyaki; M Seki; M Okamoto; A Yamanaka; Y Maeda; K Tanaka; R Kikuchi; T Iwama; T Ikeuchi; A Tonomura
Journal:  Cancer Res       Date:  1990-11-15       Impact factor: 12.701

10.  Molecular genetics for clinical management of colorectal carcinoma. 17p, 18q, and 22q loss of heterozygosity and decreased DCC expression are correlated with the metastatic potential.

Authors:  H Iino; M Fukayama; Y Maeda; M Koike; T Mori; T Takahashi; R Kikuchi-Yanoshita; M Miyaki; S Mizuno; S Watanabe
Journal:  Cancer       Date:  1994-03-01       Impact factor: 6.860

View more
  2 in total

1.  Codon 201(Gly) polymorphic type of the DCC gene is related to disseminated neuroblastoma.

Authors:  X T Kong; S H Choi; F Bessho; M Kobayashi; R Hanada; K Yamamoto; Y Hayashi
Journal:  Neoplasia       Date:  2001 Jul-Aug       Impact factor: 5.715

2.  A Multiple Interaction Analysis Reveals ADRB3 as a Potential Candidate for Gallbladder Cancer Predisposition via a Complex Interaction with Other Candidate Gene Variations.

Authors:  Rajani Rai; Jong Joo Kim; Sanjeev Misra; Ashok Kumar; Balraj Mittal
Journal:  Int J Mol Sci       Date:  2015-11-25       Impact factor: 5.923

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.